Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. freshman Avg
|
|
New words:
ablate, ablated, abroad, ACA, acid, Actimab, ADC, adult, Agile, agricultural, Ajit, allogeneic, Amgen, Amphivena, anemia, Anil, antecedent, antigen, apamistamab, aplastic, ARC, assessedin, ATM, Atypical, Australia, AWE, Bachelor, background, Baron, batch, Baxalta, Belgium, benign, bestowed, Biochemical, Biochemistry, bioequivalence, Biogen, biomarker, biomolecular, Biotechnologie, Bioxcel, Birla, bispecific, BiTE, blockbuster, BMT, Boehringer, built, Caliber, Cambridge, Carey, Carolina, CDMO, cellular, Chairperson, chelation, chelator, children, China, CIBMTR, Cincinnati, circulation, Cladribine, clarification, Cleveland, clinician, cloning, CMC, CML, CMML, coincide, column, compound, Comprehensive, conceivable, concentration, conclusion, condensed, Consortium, constitutionality, coordinate, counterpart, CyramzaTM, CytoDyn, Dale, daratumumab, darzalex, decade, decline, declined, diagnostic, disagree, distinguished, distraction, divisional, DLT, DNA, Duke, East, empowered, engraftment, entail, entrepreneurial, Erbitux, error, extramedullary, fashion, feet, formulation, Franchise, Fuqua, George, gold, grew, HIV, hope, hypomethylating, ideally, IMBRUVICA, imclone, immune, Immunogen, immunoglobulin, Importantly, inadvertently, incremental, India, infection, infirm, Ingelheim, inherited, instance, Instituut, Jadavpur, Janssen, Japan, JCC, Jesup, JNJ, John, Kapur, Kimmel, King, Korea, Lamont, LartruvoTM, Lee, Los, Louisiana, meaningful, mechanical, Mellon, Metallurgy, microbiology, mitigation, Mitoxantrone, MMA, Modernization, Moffitt, molecule, mortality, mouse, mutation, Myelosuppression, naked, narrowly, network, newer, Nitya, noncash, optimization, outright, oversaw, overturn, payload, PCAOB, Ph, Pharmaceutica, pharmacoeconomic, poorer, Portrazza, pose, postdoctoral, poster, premier, pressure, principle, Protea, quickly, radio, Ramapo, Ray, recordkeeping, red, reveal, revocation, Roboz, Roche, room, route, scenario, screening, shaping, Shetty, shipping, shut, sickle, Sidney, SIERRA, simultaneously, sit, slight, spanning, spongy, square, Squibb, step, Steve, Streicher, Supreme, Symphogen, tAML, tandem, tasked, Taussig, Tech, tenure, tetracarboxylic, text, therapeutic, tissue, top, transformation, translating, Trinity, unavailable, unfit, unforeseeable, unhindered, unlabeled, upheld, VELCADE, Verax, VIB, voor, Warhead, Weill, white, Wisconsin, withstand, workforce, wrongfully, xenograft
Removed:
Abbott, absent, accepting, accredited, acquiree, acquirer, actively, added, afford, amend, analyst, anniversary, annum, Anturol, APIT, applicability, Ardana, assisted, assumed, attorney, automatic, automatically, backing, Bath, Baylor, beam, Belgrade, biggest, BioMed, BioReliance, blank, breakthrough, Budget, capable, Carlo, ceasing, check, choice, choose, clear, CNS, collection, colon, colorectal, Columbia, commencing, comment, comparative, comparatively, competitively, comprising, conduit, confer, conflict, Congressional, consult, consultation, consuming, consummating, consummation, contractually, contributor, conventional, cooperation, crucial, cure, Cymbalta, dealt, debated, denying, deposited, depriving, designee, desire, destroying, deter, developer, direction, discharge, discouraged, division, Doctor, domicile, Dragan, easier, educated, educational, effected, efficient, eighteen, Einstein, enactment, encountered, enforceable, engineered, Erba, establishedin, estate, exchanged, exemption, exhibited, exist, expectation, extend, facilitate, facing, Farmitalia, fatal, FDIC, feasibility, FHCC, fifty, Fischer, fixed, focusing, forty, founding, gap, genetically, GMP, govern, great, greatest, Greece, growing, guiding, halted, harming, Harvard, headcount, heighten, hereinafter, hinder, hiring, historically, identified, immunology, implanted, indefinite, Index, induction, infused, ING, inhaled, injected, insight, instilled, instituted, instrumental, iodine, IRB, Isaly, IsoTex, issuable, Italy, judicially, Kaushik, Labor, largest, Laurea, Leonard, lymphoblastic, MedActinium, Medeor, Mehta, membership, merger, Merging, Merlin, metastatic, minimizing, MLV, modify, Multiforme, Munich, myeloconditioning, nearby, negotiate, negotiating, NeutroSpecTM, Nevada, Nieman, ninety, nonclinical, NRC, Obama, opportunity, organizing, orientation, OTCQB, Otrexup, outpatient, owed, Pacific, Palatin, participated, passed, people, percentile, perspective, persuaded, Pharmacia, pharmacy, Portugal, possession, preparatory, procedure, procurement, profit, projected, promissory, promotional, proper, prostate, Prozac, publicity, pursuing, QED, qualifying, rare, realizable, rebate, recapitalization, recommend, reexamination, referring, reinvestment, rejected, released, releasing, Relief, remediated, remediation, replaced, represented, resale, responding, resubmit, Rx, safer, sample, scheduled, Select, separate, SG, shell, shifted, sixty, solid, Southern, Spain, speculative, spinoff, sponsorship, stay, steering, Stern, stream, structuring, successive, suppression, survive, synthesizing, Taxpayer, thereunder, threatening, ticker, training, tranche, transactional, trillion, TUM, Turin, unapproved, unclear, undergo, undertaken, underwriter, undiscounted, uninsured, unstable, Urban, vendor, vi, vii, vision, wealth, Wharton, wide, wider, Yeshiva, yttrium, Zurich, Zyprexa
Filing tables
Filing exhibits
- 10-K Annual report
- 10.56 Sixth Amendment to the 2013 Amended and Restated Stock Plan, As Amended
- 10.57 Offer Letter, Effective January 2, 2018, Between Dale L. Ludwig and Actinium Pharmaceuticals, Inc
- 10.58 Indemnification Agreement, Dated January 5, 2018, Between Dale L. Ludwig and Actinium Pharmaceuticals, Inc.
- 10.59 Offer Letter, Effective January 31, 2018, Between Anil Kapur and Actinium Pharmaceuticals, Inc.
- 10.60 Indemnification Agreement, Dated February 8, 2018, Between Anil Kapur and Actinium Pharmaceuticals, Inc.
- 23.1 Consent of GBH Cpas, PC
- 31.1 Certification
- 31.2 Certification
- 32.1 Certification
- 32.2 Certification
- Download Excel data file
- View Excel data file
ATNM similar filings
Filing view
External links
Exhibit 32.1
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER, PURSUANT TO
18 U.S.C. SECTION 1350,AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of Actinium Pharmaceuticals, Inc. a Delaware corporation (the “Company”), on Form 10-K for the period ended December 31, 2017 as filed with the Securities and Exchange Commission (the “Report”), I, Sandesh Seth, Chief Executive Officer of the Company, certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350), that to my knowledge:
(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
/s/ Sandesh Seth
Sandesh Seth
Chairman and Chief Executive Officer
(Principal Executive Officer)
Date: March 16, 2018